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ABSTRACT 
 
Varp (VPS9-ankyrin repeat protein) in melanocytes is thought to function as a key 
player in pigmentation of mammals.  Varp regulates two different melanocyte 
functions, i.e., transport of melanogenic enzymes to melanosomes by functioning as a 
Rab32/38 effector, and promotion of dendrite outgrowth by functioning as a 
Rab21-guanine nucleotide exchange factor.  The Varp protein level has recently been 
shown to be negatively regulated by proteasomal degradation through interaction of the 
ankyrin repeat 2 (ANKR2) domain of Varp with Rab40C.  However, the molecular 
mechanisms by which Varp escapes from Rab40C and retains its own expression level 
remain completely unknown.  Here, we identified RACK1 (receptor of activated 
protein kinase C 1) as a novel Varp-ANKR2-binding partner and investigated its 
involvement in Varp stabilization in mouse melanocytes.  The results showed that 
knockdown of endogenous RACK1 in melanocytes caused dramatic reduction of the 
Varp protein level and inhibition of dendrite outgrowth, and intriguingly, overexpression 
of RACK1 inhibited the interaction between Varp and Rab40C and counteracted the 
negative effect of Rab40C on dendrite outgrowth.  These findings indicated that 
RACK1 competes with Rab40C for binding to the ANKR2 domain of Varp and 
regulates dendrite outgrowth through stabilization of Varp in mouse melanocytes. 
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INTRODUCTION 
 
Melanocytes are unique cells that play an important role in producing pigmented 
organelles, called melanosomes, that protect cells against ultraviolet injury (Raposo and 
Marks, 2007).  Melanocytes originate from the embryonic neural crest cells of 
mammals, and the embryonic neural crest cells migrate and differentiate into 
melanocytes in the basal layer of the epidermis and in the hair bulbs (Cichorek et al., 
2013).  Skin and hair become pigmented as a result of a process that consists of several 
steps.  In the first step, mature melanosomes are produced around the nucleus 
(melanosome biogenesis step).  In the next step, the mature melanosomes are 
transported (melanosome transport step) along the two cytoskeletal components, 
microtubules and actin filaments, and then transferred to surrounding keratinocytes 
through the melanocyte dendrites (melanosome transfer step).  The melanocyte 
dendrites are specialized cell structures that form and contact surrounding keratinocytes 
and hair matrix cells (dendrite outgrowth step) in response to growth factors and 
ultraviolet irradiation (Ohbayashi and Fukuda, 2012; Wu and Hammer, 2014).  Each of 
these steps is thought to be crucial to pigmentation, because genetic defects in one of 
these steps have been reported to cause albinism, a group of hereditary diseases that are 
characterized by hypopigmentation of the hair and skin, e.g., Griscelli syndrome, 
Hermansky-Pudlak syndrome, and Chédiak-Higashi syndrome (Tomita and Suzuki, 
2004; Di Pietro and Dell’Angelica, 2005; Van Gele et al., 2009).  Genetic analysis of 
these diseases and their corresponding coat color mutant mice in the past few decades 
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have revealed their causative genes, and further characterization of the gene products 
has enabled identification of a variety of their binding proteins and regulators that 
participate in skin and hair pigmentation, e.g., BLOC (biogenesis of lysosome-related 
organelles complex) (Wei and Li, 2013) and small GTPase Rab38 (Loftus et al., 2002). 
 Varp (VPS9-ankyrin repeat protein) is one such protein that functions as an 
effector molecule for the small GTPase Rab38 (Tamura et al., 2009), a deficiency of 
which causes the diluted coat color of chocolate mice (Loftus et al., 2002), one of the 
mouse models of Hermansky-Pudlak syndrome (Wei and Li, 2013).  Varp is a 
pleiotropic regulator of melanogenesis, because it promotes dendrite formation through 
activation of Rab21 via its N-terminal VPS9 domain (Zhang et al., 2006; Ohbayashi et 
al., 2012b), and melanogenic enzyme transport to melanosomes via its ankyrin repeat 1 
(ANKR1) domain, which binds Rab32/38 (Wang et al., 2008; Tamura et al., 2009; 
Tamura et al., 2011).  In addition, binding of VAMP7 to a VAMP7-interaction domain 
(VID) of Varp (Burgo et al., 2009; Schäfer et al., 2012) is required for both dendrite 
outgrowth and melanogenic enzyme transport (Tamura et al., 2011).  The results of 
recent proteomic analyses have revealed the presence of additional Varp binding 
partners, including retromer, GolginA4, and Kif5A, in non-melanocytic cells (Burgo et 
al., 2012; Hesketh et al., 2014; McGough et al., 2014), but their involvement in 
melanogenesis is poorly understood.  More recently, we have shown that Rab40C 
binds to a C-terminal ANKR2 domain of Varp and that the binding promotes 
proteasomal degradation of Varp through recruiting a Cullin-type ubiquitin ligase 
complex (Yatsu et al., 2015).  However, the molecular mechanism by which Varp 
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escapes from Rab40C-mediated degradation remains completely unknown, and the 
presence of an additional as yet unknown Varp binding partner(s) that regulates the 
interaction between Rab40C and the ANKR2 domain of Varp in melanocytes is 
assumed. 
 In this study, we screened for a novel Varp ANKR2-domain-binding protein 
by performing yeast-two hybrid assays and succeeded in identifying RACK1 (receptor 
of activated protein kinase C 1: also known as Gnb2l1) as a candidate.  RACK1 was 
originally described as an anchoring protein for activated PKC (Ron et al., 1994), 
and it has subsequently been shown to function as a scaffold protein that is involved in a 
variety of cellular events, including translation, apoptosis, and migration (Serrels et al., 
2011; Gandin et al., 2013; Li and Xie, 2014).  The results of our biochemical assays 
showed that the interaction between RACK1 and Varp was increased by forskolin, 
which increased the intracellular cAMP concentration and induced dendrite outgrowth 
of melanocytes (Ohbayashi et al., 2012b), and that RACK1 had the ability to reduce 
Rab40C binding to the ANKR2 domain of Varp by competitively binding to it.  
Moreover, knockdown of endogenous RACK1 in melanocytes in our study caused a 
dramatic reduction in the amount of Varp protein and in forskolin-induced dendrite 
outgrowth.  Based on our findings, we discuss a novel role of RACK1 in protecting 
Varp protein from Rab40C during dendrite outgrowth of melanocytes and its relation to 
albinism. 
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RESULTS 
 
Identification of RACK1 as a novel Varp-binding protein 
To identify novel Varp ANKR2-domain-binding partners, we performed yeast 
two-hybrid screening with the Varp ANKR2 domain used as bait (Figure 1a).  We 
screened approximately 1.8 × 106 colonies of a mouse cDNA library and obtained 40 
positive clones.  We especially focused on the candidate protein, RACK1, because 
three independent prey clones were obtained for RACK1 (Figure 1b; clone #2 was not 
depicted because of its incomplete sequence), whereas only one or two positive clones 
were obtained for other candidate proteins.   Because the two completely sequenced 
(#1 and #3) of the three RACK1 clones contained part of the C-terminal sequence of 
RACK1, we prepared a RACK1N mutant (amino acids 204–317) and performed yeast 
two-hybrid assays to investigate its binding activity in relation to three Varp truncated 
mutants (Figure 1a).  As expected, the RACK1N construct specifically interacted 
with the ANKR2 domain and did not interact at all with the N+VPS9 domain or the 
ANKR1 domain (Figure 1c).  In addition, we confirmed the interaction between 
full-length Varp and RACK1 in mammalian cultured cells by performing 
co-immunoprecipitation assays (Figure 1d, lane 4 in the middle panel).  We also 
confirmed the endogenous interaction between Varp and RACK1 by using specific 
antibodies (Figure 1f).  Because RACK1 has previously been shown to be involved in 
several signaling pathways, including a cAMP pathway and a PKC pathway (Adams et 
al., 2011), we treated cells with a PKC activator, 12-O-tetradecanoylphorbol 13-acetate 
8 
(TPA), and a PKA activator, forskolin.  Intriguingly, the interaction between Varp and 
RACK1 was significantly increased by forskolin, whereas TPA had no effect at all 
(Figure 1d, lanes 5 and 6 in the middle panel, and e). 
 
Knockdown of RACK1 in melanocytes induces Varp degradation and inhibition of 
dendrite outgrowth 
The finding that the Varp–RACK1 interaction was increased by forskolin led us to 
investigate the involvement of RACK1 in the forskolin-induced dendrite outgrowth of 
melanocytes (Ohbayashi et al., 2012b), because melanocyte dendrite outgrowth is the 
only forskolin-dependent phenomenon in which Varp has been reported to be involved 
in the literature.  First, we investigated whether RACK1 is endogenously expressed in 
melanocytes.  Since the results of immunoblotting and RT (reverse transcription)-PCR 
analysis indicated that RACK1 is actually expressed in mouse melan-a cells (Figure 2a, 
lane 1 in the top panel, and c, left graph), we proceeded to investigate whether RACK1 
is involved in dendrite outgrowth of melanocytes.  To do so, we prepared two 
independent sites of RACK1 siRNAs, both of which efficiently knocked down 
endogenous RACK1 protein (Figure 2a, top panel) as well as RACK1 mRNA in the 
melanocytes (Figure 2c, left graph), and the results showed that the knockdown of 
RACK1 strongly inhibited forskolin-induced dendrite outgrowth (Figure 3a and b), the 
same as Varp knockdown did (Ohbayashi et al., 2012b).  Furthermore, knockdown of 
RACK1 also resulted in a significant decrease in the number of dendrites/cell (Control 
siRNA, 2.22 ± 0.11; RACK1 siRNA st1, 1.62 ± 0.09; and RACK1 siRNA st2, 1.27 ± 
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0.10 (mean ± SEM); P<0.01).  To our surprise, there was a concomitant decrease in 
the amount of Varp protein in the RACK1-knockdown melanocytes (Figure 2a, middle 
panel, and b), and yet RACK1 knockdown had no significant effect on the level of Varp 
mRNA expression (Figure 2c, right graph).  The lower level of Varp protein in the 
RACK1-knockdown cells is likely to have been attributable to proteasomal degradation, 
because treatment of the cells with proteasome inhibitor MG132 resulted in partial 
recovery of its protein level (Figure 2d, middle panel).  These results indicated that 
RACK1 is most likely involved in dendrite outgrowth of forskolin-stimulated 
melanocytes through regulation of the Varp protein expression level. 
 
RACK1 inhibits the interaction between Varp and Rab40C 
Because the Varp protein expression level is negatively controlled by Rab40C through 
proteasomal degradation and because Rab40C interacts with the ANKR2 domain of 
Varp (Yatsu et al., 2015), the same as RACK1 does (Figure 1c), we hypothesized that 
RACK1 protects Varp protein from proteasomal degradation by inhibiting the 
interaction between Rab40C and Varp.  To test our hypothesis, we expressed 
T7-tagged Varp and FLAG-tagged Rab40C (or EGFP as a control) with or without 
HA-tagged RACK1 in COS-7 cells and performed co-immunoprecipitation assays 
(Figure 4a).  The results showed that expression of HA-RACK1 dramatically 
decreased the amount of Varp that co-immunoprecipitated with Rab40C (Figure 4a, 
lanes 2 and 3 in the second panel, and b), indicating that RACK1 effectively inhibits the 
interaction between Varp and Rab40C in vitro.  Consistent with this result, the effect 
10 
of the RACK1 knockdown on the Varp protein level (i.e., decreased Varp protein level) 
in melanocytes was clearly attenuated by simultaneous knockdown of Rab40C (Figure 
4c, lanes 2 and 4 in the middle panel, and d). 
 Finally, we investigated whether RACK1 antagonizes the effect of Rab40C 
on the Varp protein expression level during dendrite outgrowth.  To do so, we 
expressed RACK1 with or without Rab40C in forskolin-stimulated melanocytes and 
evaluated its effect on dendrite outgrowth.  Expression of mStr-RACK1 alone (+ 
EGFP as mock control) in forskolin-stimulated melanocytes had no effect on dendrite 
outgrowth (Figure 5a, second row, and b), whereas expression of EGFP-Rab40C alone 
(+ mStr as mock control) significantly inhibited forskolin-induced dendrite outgrowth 
(Figure 5a, third row, and b).  By contrast, simultaneous expression of EGFP-Rab40C 
and mStr-RACK1 in forskolin-stimulated melanocytes completely restored dendrite 
outgrowth to the mock control (EGFP/mStr) level (Figure 5a, bottom row, and b), and 
the rescue effect of RACK1 on dendrite outgrowth was canceled when endogenous 
Varp was knocked down in EGFP-Rab40C+mStr-RACK1-expressing cells 
(Supplementary Figure S1).  A similar tendency was observed in regard to the numbers 
of dendrites of the forskolin-stimulated cells: expression of EGFP-Rab40C alone 
slightly decreased the number of dendrites/cell, but the decrease was not statistically 
significant (mStr+EGFP, 2.15 ± 0.10; mStr-RACK1+EGFP, 2.15 ± 0.09; 
mStr+EGFP-Rab40C, 2.01 ± 0.07; and mStr-RACK1+EGFP-Rab40C, 2.25 ± 0.07 
(mean ± SEM)).  Taken together, these results indicated that RACK1 has the ability to 
protect Varp protein from Rab40C and promotes forskolin-induced dendrite outgrowth 
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of melanocytes. 
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DISCUSSION 
 
We previously identified Rab40C as a negative regulator of the Varp protein expression 
level in melanocytes that induces proteasomal degradation of Varp through interaction 
with the ANKR2 domain (Yatsu et al., 2015).  However, the molecular mechanism by 
which Varp protein escapes from Rab40C remained unknown, and no attempt had ever 
been made to identify a positive regulator of the Varp protein expression level that 
counteracts the Varp degradation caused by Rab40C.  In the present study, we 
identified RACK1 as a novel Varp ANKR2-domain-binding protein by yeast two-hybrid 
screening and demonstrated that forskolin, which increases the intracellular cAMP level 
by activating adenylate cyclase, increases the interaction between RACK1 and Varp 
(Figure 1).  Because Varp has been shown to regulate forskolin-induced dendrite 
outgrowth of melanocytes (Ohbayashi et al., 2012b), we proceeded to investigate the 
functional involvement of RACK1 in this process by knockdown and overexpression 
experiments.  The results showed that RACK1 is actually required for stabilization of 
Varp protein (i.e., for prevention of Varp proteasomal degradation) but does not affect 
the Varp mRNA level (Figure 2) and that knockdown of RACK1 inhibited 
forskolin-induced dendrite outgrowth (Figure 3), the same as Varp knockdown did 
(Ohbayashi et al., 2012b).  More importantly, RACK1 has the ability to compete with 
Rab40C for binding to the Varp ANKR2 domain in vitro (Figure 4), and the inhibitory 
effect of Rab40C on dendrite outgrowth in forskolin-stimulated melanocytes was fully 
restored by simultaneous expression of RACK1 (Figure 5).  These results taken 
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together indicated that RACK1 is a positive regulator of the Varp protein expression 
level in melanocytes that directly competes with a negative regulator Rab40C for 
binding to the ANKR2 domain (see model in Supplementary Figure S2).  The 
molecular mechanism by which the RACK1–Varp interaction is regulated by forskolin 
is completely unknown, but because RACK1 interacts with many kinases, including 
PKC, Src, and MAPK (Adams et al., 2011), phosphorylation is likely to regulate the 
interaction.  Further research will be necessary to determine whether phosphorylation 
(or post-translational modification(s)) of RACK1 (or Varp) actually regulates the 
interaction between Varp and RACK1 or Rab40C during skin pigmentation. 
 Although in the present study we focused on the role of RACK1 in 
forskolin-induced dendrite outgrowth, RACK1 may also contribute to 
forskolin-independent functions of Varp, e.g., melanogenic enzyme transport, in 
melanocytes (Tamura et al., 2009; Tamura et al., 2011; Marubashi et al., 2016), because 
the RACK1–Varp interaction occurs even in the absence of forskolin (Figure 1d).  
Actually, RACK1 has previously been reported to be present on melanosomes in human 
primary melanocytes with an unknown mechanism and to regulate tyrosinase activity by 
recruiting PKC (Park et al., 2004).  Moreover, knockdown of RACK1 in melan-a 
cells caused disappearance of tyrosinase signals from melanosomes without altering the 
tyrosinase mRNA level and decreased melanin content as well, the same as Varp 
knockdown did (Supplementary Figure S3), suggesting that protection of Varp protein 
by RACK1 from Rab40C-mediated degradation is also crucial for melanogenic enzyme 
transport to melanosomes in melanocytes.  Intriguingly, it has recently been reported 
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that RACK1 heterozygous mice exhibit skin pigmentation defects characterized by a 
white belly spot and hypopigmented tail and paws, while RACK1 homozygous mice die 
at an early embryonic stage (Volta et al., 2013).  The hypopigmented phenotype may 
be mainly attributable to defects in dendrite outgrowth (Figure 3) and in melanin 
synthesis (Park et al., 2004; Supplementary Figure S3), both of which are crucial for 
pigmentation and are regulated by Varp protein (Tamura et al., 2009; Ohbayashi et al., 
2012b). 
 Because both RACK1 and Varp are expressed in non-melanocytic cells, 
RACK1-dependent stabilization of Varp protein may be retained in cells other than 
melanocytes and their interaction may be involved in retromer-dependent cargo 
transport pathways (Hesketh et al., 2014; McGough et al., 2014) and neurite outgrowth, 
both of which are positively regulated by Varp (Burgo et al., 2009; Burgo et al., 2012).  
It is noteworthy that RACK1 is highly expressed in mouse brain (Ashique et al., 2006) 
and has been shown to regulate neurite outgrowth through interaction with molecules 
other than Varp (Ensslen and Brady-Kalnay, 2004; Ceci et al., 2012; Dwane et al., 
2014).  Further investigation of the RACK1–Varp complex in neurite outgrowth will 
clarify the universal role of RACK1 in Varp protein stabilization. 
 In conclusion, the results of this study have revealed a novel function of the 
ANKR2 domain of Varp, i.e., RACK1-mediated stabilization of Varp protein in 
melanocytes.  Based on our findings, we propose that the ANKR2 domain of Varp 
fine-tunes the level of Varp protein expression through interaction with either a positive 
regulator, RACK1 (this study), or a negative regulator, Rab40C (Yatsu et al., 2015) 
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rather than directly regulating melanogenesis.  Dysregulation of this process may lead 
to skin pigmentation defects, including impaired melanin synthesis and impaired 
dendrite outgrowth.
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MATERIALS AND METHODS 
 
Materials 
Anti-Varp guinea pig polyclonal antibody and anti-tyrosinase rabbit polyclonal antibody 
were prepared as described previously (Beaumont et al., 2011; Yatsu et al., 2015).  The 
following antibodies used in this study were obtained commercially: anti-RACK1 
mouse monoclonal antibody (Santa Cruz Biotechnology, Dallas, TX), anti--actin 
mouse monoclonal antibody (Applied Biological Materials, Richmond, BC, Canada), 
HRP (horseradish peroxidase)-conjugated anti-FLAG tag (M2) mouse monoclonal 
antibody, anti-FLAG tag antibody-conjugated agarose (Sigma-Aldrich Corp., St. Louis, 
MO), HRP-conjugated anti-T7 tag mouse monoclonal antibody (Merck Millipore, 
Billerica, MA), and HRP-conjugated anti-HA tag (3F10) rat monoclonal antibody 
(Roche Applied Science, Penzberg, Germany).  Forskolin and TPA were from 
Sigma-Aldrich.  The proteasome inhibitor MG132 and N-ethylmaleimide were 
obtained from Peptide Institute (Osaka, Japan) and Wako Pure Chemical Industries 
(Osaka, Japan), respectively. 
 
Plasmid construction 
Plasmids encoding mouse Varp (N+VPS9, ANKR1, and ANKR2), Rab40C, and EGFP 
were prepared as described previously (Tamura et al., 2009; Yatsu et al., 2015).  The 
cDNA of Varp-ANKR2 (amino acid residues 730–1048) (Yatsu et al., 2015) was 
subcloned into the pGBKT7 vector (Clontech-Takara Bio Inc., Shiga, Japan) for yeast 
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two-hybrid screening.  The cDNA of mouse RACK1 was amplified from 
Marathon-Ready mouse brain and testis cDNAs (Clontech-Takara Bio Inc.) by 
performing PCR with the following pair of oligonucleotides containing a BamHI linker 
(underlined) or a stop codon (boldface): forward primer, 
5’-GGATCCATGACCGAGCAGATGACCCT-3’ and reverse primer, 
5’-TTAGCGGGTACCAATAGTTA-3’.  The RACK1 cDNAs obtained were subcloned 
into the pEF-T7 tag vector (Fukuda et al., 1999), pEF-HA tag vector (Fukuda, 2002), 
pmStr-C1 vector (Ohbayashi et al., 2012a), and pGBD-C1 vector (James et al., 1996).  
A RACK1mutant (deletion of amino acid residues 1–203 of mouse RACK1) was 
prepared by removing the BamHI insert of the pGBD-C1-RACK1 vector (an intrinsic 
BamHI site in the RACK1 cDNA and BamHI site in the multi-cloning site of the vector) 
and by self-ligating the vector.  Small interfering RNAs (siRNAs) against mouse 
RACK1 (target site 1: 5’-GGATGAGAGTCATTCAGAA-3’ and target site 2; 
5’-GACCAACTATGGCATACCA-3’) and mouse Rab40C (target site: 
5’-CTGCATGACCTTCTTTGAA-3') were chemically synthesized by Nippon Gene Co., 
Ltd. (Toyama, Japan).  Knockdown efficiency of the Rab40c siRNA has already been 
shown by RT-PCR in our previous study (Yatsu et al., 2015). 
 
Forskolin-induced dendrite formation of melanocytes 
The black-mouse-derived immortal melanocyte cell line melan-a (generous gift of 
Dorothy C. Bennett) was cultured on 12-mm diameter coverslips as described 
previously (Bennett et al., 1987; Kuroda et al., 2003).  Plasmids and siRNAs were 
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transfected into melan-a cells by using Lipofectamine 2000 (Invitrogen) according to 
the manufacturer’s instructions.  One day after transfection the cells were treated with 
20 M forskolin or DMSO alone (control), and 20 hours later they were fixed with 4% 
paraformaldehyde and examined for fluorescence with a confocal laser-scanning 
fluorescence microscope (Fluoview FV1000-D; Olympus, Tokyo, Japan).  The images 
of the EGFP-expressing cells were captured at random with the confocal microscope, 
and the total length of their dendrites was measured with ImageJ software 
(version1.48u4; NIH, Bethesda, MD) as described previously (Ohbayashi et al., 2012b).  
In brief, the length of each dendrite of a cell was measured from the edge of the cell 
body (cell body–dendrite boundary was determined to be a cross point by extrapolating 
the cell membrane) to the tip of dendrite, and total dendrite length means the sum of the 
lengths of all of the dendrites of the cell.  Each experiment was performed 
independently at least three times, and the numbers of cells analyzed in each experiment 
are stated in the figure legends.  The statistical analyses were performed by using 
Dunnett’s test, Tukey’s test, or Student’s unpaired t-test, and P values <0.05 were 
considered statistically significant (*, P<0.05; **, P<0.01).  
 
Immunoblotting 
siRNAs were transfected into melan-a cells by using Lipofectamine RNAiMAX 
(Invitrogen) according to the manufacturer’s instructions.  At 48 hours after 
transfection the cells were washed with ice-cold PBS and lysed with the lysis buffer (50 
mM HEPES-KOH pH7.2, 150 mM NaCl, 1 mM MgCl2, and 1% Triton X-100 
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supplemented with complete EDTA-free protease inhibitor cocktail (Roche Applied 
Science)).  In Figure 2d, at 6 hours after transfection the cells were treated with 1 nM 
proteasome inhibitor MG132 or DMSO and then were cultured for 48 hours.  The cells 
were washed with ice-cold PBS and lysed with 50 mM HEPES-KOH pH 7.2, 150 mM 
NaCl, 1 mM MgCl2, 0.1% (w/v) sodium deoxycholate, 1% (w/v) SDS, and 10 mM 
N-ethylmaleimide supplemented with complete EDTA-free protease inhibitor cocktail.  
The lysates were subjected to 7.5% (or 8.8%) SDS-PAGE and transferred to a PVDF 
membrane (Merck Millipore) by electroblotting.  The blots were blocked with 1% 
skim milk or 1% BSA in PBS containing 0.1% Tween-20 and incubated at room 
temperature with primary antibodies for 1 hour and then with appropriate 
HRP-conjugated secondary antibodies for 1 hour.  Immunoreactive bands were 
detected by enhanced chemiluminescence (ECL, GE Healthcare Ltd., Little Chalfont, 
UK).  The intensity of the immunoreactive bands was measured with ImageJ software.  
The positions of the molecular mass markers (in kDa) are shown on the left of each 
figure. 
 
Co-immunoprecipitation assays 
COS-7 cells (4 105 cells/60-mm dish) were co-transfected with plasmids (indicated in 
Figures 1 and 4) by using Lipofectamine LTX Plus (Invitrogen) according to the 
manufacturer’s instructions.  At 36 hours after transfection the cells were lysed with 
the lysis buffer.  Co-immunoprecipitation assays with anti-FLAG tag 
antibody-conjugated agarose beads (Sigma-Aldrich) were performed as described 
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previously (Fukuda et al., 1999; Fukuda and Kanno, 2005), and proteins bound to the 
beads were analyzed by immunoblotting as described above.  Endogenous interaction 
between Varp and RACK1 in melan-a cells that had been treated with 20 M forskolin 
for 3 hours was also investigated by co-immunoprecipitation assays with anti-RACK1 
antibody as described previously (Fukuda and Kanno, 2005). 
 
Other methods, including yeast two-hybrid assays, RT-PCR analysis, melanin assay, and 
tyrosinase staining, are available at online supplementary material. 
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FIGURE LEGENDS 
 
Figure 1.  RACK1 is a novel Varp-interacting protein.  (a) Schematic 
representation of Varp and its truncated mutants used in this study.  (b) Schematic 
representation of RACK1 protein and its corresponding mRNA.  (c) Interaction of 
RACK1N with Varp truncated mutants as revealed by yeast two-hybrid assays.  (d) 
Interaction between T7-RACK1 and full-length FLAG-Varp.  Before harvesting, the 
transfected COS-7 cells were stimulated for 3 hours with 20 M forskolin (Fsk), 20 nM 
TPA, or DMSO alone.  FLAG-EGFP was used as a negative control.  (e) 
Quantification of T7-RACK1 bands shown in the middle panel in d.  The bars 
represent the means and SEM of three independent experiments.  *, P<0.05 in 
comparison with DMSO (Dunnett’s test).  (f) Endogenous interaction between 
RACK1 and Varp (arrowhead) in FSK-treated mouse melanocytes (melan-a cells). 
 
Figure 2.  Knockdown of RACK1 in melanocytes decreases their level of Varp 
protein expression.  (a) Reduced expression of Varp in RACK1-knockdown melan-a 
cells as revealed by immunoblotting with the antibodies indicated.  (b) Quantification 
of Varp bands shown in the middle panel in a.  The bars represent the means and SEM 
of six independent experiments.  *, P<0.05; **, P<0.01 in comparison with the control 
(Dunnett’s test).  (c) Knockdown efficiency of RACK1 siRNAs as revealed by 
real-time quantitative RT-PCR analysis. **, P<0.01 (Dunnett’s test).  (d) Exposure of 
RACK1-knockdown melan-a cells to MG132 or DMSO for 48 hours.  Representative 
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data from one of three independent experiments with similar results are shown. 
 
Figure 3.  Knockdown of RACK1 inhibits dendrite outgrowth of melanocytes.  
(a) Melan-a cells were cotransfected with RACK1 siRNA (st1 or st2) or control siRNA 
and pEGFP-C1 (transfection marker) and then stimulated for 20 hours with 20 M 
forskolin (Fsk) or DMSO alone.  Images of EGFP-expressing cells were captured at 
random, and typical images of RACK1-knockdown cells (EGFP-expressing cells) are 
shown.  Scale bars, 50 m.  (b) Quantification of total dendrite length/cell shown in a.  
The bars represent the means and SEM of data from three independent experiments 
(totally 145 cells were analyzed).  *, P<0.05; **, P<0.01 in comparison with the 
control (Dunnett’s test). 
 
Figure 4.  RACK1 inhibits the interaction between Varp and Rab40C.  (a) COS-7 
cells transiently expressing T7-Varp and FLAG-Rab40C (or FLAG-EGFP as a control) 
with or without HA-RACK1 were lysed, and the interaction between T7-Varp and 
FLAG-Rab40C was evaluated by immunoprecipitation with anti-FLAG tag 
antibody-conjugated agarose beads followed by immunoblotting with the antibodies 
indicated.  (b) Quantification of Varp bands shown in the second panel in a 
(normalized to the input).  The bars represent the means and SEM of data from four 
independent experiments.  (c) The Varp protein level in RACK1-, Rab40C-, and 
RACK1/Rab40C-knockdown melan-a cells.  (d) Quantification of Varp bands shown 
in c (normalized to actin bands).  The bars represent the means and SEM of data from 
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five independent experiments (normalized to control).  *, P<0.05 (Student’s unpaired 
t-test). 
 
Figure 5.  RACK1 rescues Rab40C inhibition of dendrite outgrowth of 
melanocytes.  (a) Melan-a cells co-expressing EGFP-Rab40C (or EGFP alone) and 
mStr-RACK1 (or mStr alone) were stimulated for 20 hours with 20 M forskolin (Fsk) 
or DMSO alone.  Images of the cells expressing both EGFP-tagged and mStr-tagged 
proteins were captured at random, and typical images are shown.  Scale bars, 50 m.  
(b) Quantification of total dendrite length/cell shown in a.  The bars represent the 
means and SEM of data from one representative experiment (n=110 cells).  **, P<0.01 
(Tukey’s test). 
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SUPPLEMENTARY MATERIAL 
 
Supplementary Methods 
 
Yeast two-hybrid assays 
Yeast two-hybrid screening was performed by using pGBKT7-Varp-ANKR2 as bait and 
mouse testis and mouse 11-day embryo mixed cDNA libraries (Clontech-Takara Bio 
Inc.) as prey according to the manufacturer’s instructions.  Yeast two-hybrid assays 
were performed by using pGBD-C1-RACK1and pAct2-Varp-N+VPS9, 
pAct2-Varp-ANKR1, or pAct2-Varp-ANKR2 as described previously (Tamura et al., 
2009).  The yeast strain (pJ69-4A), SC-LW medium (synthetic complete medium 
lacking leucine and tryptophan), selection medium SC-AHLW (synthetic complete 
medium lacking adenine, histidine, leucine, and tryptophan), culture conditions, and 
transformation protocol used are described elsewhere (James et al., 1996; Kobayashi et 
al., 2015).  Yeast cells containing both pGBD-C1-RACK1N and each of the pAct2 
plasmids expressing a Varp mutant were each streaked on both SC-LW medium and 
SC-AHLW medium and incubated at 30˚C for 1 day and 1 week, respectively. 
 
RT (reverse transcription)-PCR analysis 
The total RNA of melan-a cells transfected with RACK1 siRNA (st1 or st2) or control 
siRNA was prepared with TRI-reagent (Sigma-Aldrich), and reverse transcription was 
performed by using ReverTra Ace® (Toyobo, Osaka, Japan) according to the 
2 
manufacturer’s instructions.  Real-time quantitative PCR was performed with SYBR 
Green and Light Cycler 2.0 (Roche Applied Science) according to the manufacturer’s 
instructions.  The following pairs of oligonucleotides were used for amplification: for 
RACK1, forward primer, 5’-GTACACGGTCCAGGATGAG-3’ and reverse primer, 
5’-GGCCAATGTGGTTGGTCTTTA-3’; for Varp, forward primer, 
5’-ACATCCTGAACAAGAGGCAGTA-3’ and reverse primer, 
5’-CCTGATCTCAACAGTCACGTA-3’; for tyrosinase, forward primer, 5’- 
GGGATGAGAACTTCACTGTTCCATA-3’ and reverse primer, 
5’-TGATCTGCTACAAATGATCTGCC-3’; and for GAPDH, forward primer, 5’- 
CATGGCCTTCCGTGTTCCTA-3’ and reverse primer, 5’- 
GAGTTGCTGTTGAAGTCGC-3’.  qPCR data were normalized to GAPDH and 
expressed as means and SEM of four independent experiments. 
 
Melanin assay and tyrosinase staining 
The melanin content was assayed as described previously (Tamura et al., 2009).  In 
brief, melan-a cells that had been transfected with RACK1 siRNAs were cultured for 4 
days and their melanin content normalized to protein content was measured as optical 
density at 490 nm.  Tyrosinase staining was also performed as described previously 
(Yatsu et al., 2015). 
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Supplementary Figure legends 
 
Supplementary Figure S1.  RACK1 is unable to rescue Rab40C inhibition of 
dendrite outgrowth of Varp-knockdown melanocytes.  (a) Melan-a cells 
co-expressing EGFP-Rab40C and mStr-RACK1 (or mStr alone) or Varp-knockdown 
cells co-expressing EGFP-Rab40C and mStr-RACK1 were stimulated for 20 hours with 
20 M forskolin (Fsk).  Images of the cells expressing both EGFP-tagged and 
mStr-tagged proteins were captured at random, and typical images are shown.  Scale 
bars, 50 m.  (b) Quantification of total dendrite length/cell shown in a.  The bars 
represent the means and SEM of data from three independent experiments (totally 90 
4 
cells were analyzed).  *, P<0.05; **, P<0.01 (Tukey’s test). 
 
Supplementary Figure S2.  A proposed model of the regulation of the Varp 
protein expression level by RACK1 and Rab40C in melanocytes.  In this model, 
Rab40C (negative regulator; Yatsu et al., 2015) and RACK1 (positive regulator; this 
study) competitively bind to the ANKR2 domain of Varp, and this competitive 
mechanism fine-tunes the level of Varp protein expression in melanocytes.  Forskolin 
(Fsk) increases the interaction between RACK1 and Varp (Figure 1), and the 
stabilization of Varp protein contributes to promoting dendrite outgrowth of 
melanocytes. 
 
Supplementary Figure S3.  Knockdown of RACK1 decreases the protein 
expression level of tyrosinase in melanocytes.  (a) Reduced expression of tyrosinase 
in RACK1-knockdown cells as revealed by immunoblotting with the antibodies 
indicated.  (b) Unaltered expression level of tyrosinase mRNA in RACK1-knockdown 
cells as revealed by real-time quantitative RT-PCR analysis.  (c) Reduced signals of 
tyrosinase in RACK1-knockdown melanocytes.  Scale bars, 20 m.  (d) 
Quantification of tyrosinase intensity shown in c.  The bars represent the means and 
SEM of data from one representative experiment (n=120 cells).  **, P<0.01 in 
comparison with the control (Dunnett’s test).  (e) Reduced melanin content in 
RACK1-knockdown melanocytes.  The bars represent the means and SEM of data 
from five independent experiments.  **, P<0.01 (Student’s unpaired t-test). 
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